The first one is dominant in e.g., colorectal cancers and hepatocellular carcinoma, with loss-of-function mutations in APC prevalent in the former, and gain-of-function mutations in β-catenin or loss-of-function mutations in Axin prevailing in the latter [29,30]. The gene discussed is APC; the disease is colorectal cancer.